Doximity (DOCS) closed at $41.36 on the latest trading day, down 5.7%, compared to a 0.19% loss in the S&P 500 and a 0.8% drop in the Dow. Over the past month, Doximity’s shares have declined by 1.77%, underperforming the Medical sector’s 0.48% gain and the S&P 500’s 2.26% rise.
The company is set to report its earnings, with an expected EPS of $0.44, reflecting a 2.22% decrease year-over-year, while projected revenue is $181.03 million, a 7.37% increase from the same quarter last year. For the entire year, earnings are forecasted at $1.56 per share and revenues at $645.29 million, representing increases of 9.86% and 13.13%, respectively.
Doximity holds a Zacks Rank of #2 (Buy), with a current Forward P/E ratio of 28.04, slightly lower than the industry average of 29.42. The company’s PEG ratio stands at 1.48, compared to the industry average of 2.33, indicating a relatively favorable valuation.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
